In a data-driven world, the ability to analyze and interpret information is critical. Harvard University’s Professional ...

Background Is being famous a risk factor for premature death? Previous studies indicate that famous musicians have a higher ...

PIN-5018 is an oral CK1α degrader developed based on the novel hypothesis of "synthetic activation of p53." The company is evaluating PIN-5018 as both a monotherapy and in multiple combination ...

Methods We analysed data on family material assets and self-reported symptoms of problematic gaming from 58 881 participants in the 2021/2022 Italian Health Behaviour in school-aged children study.

Background Percutaneous ventricular assist devices (pVAD) have been increasingly used to support haemodynamics during ...

PIN-5018 achieves complete response in ACC PDX models Expansion planned into mCRPC, colorectal cancer, and other rare tumours ...

New clinical data from the MATCH Phase II study shows early improvement in liver function after treatment with non-engineered macrophages is associated with positive long term clinical outcomesNew ...

Pin Therapeutics, a clinical-stage biotechnology company specializing in targeted protein degradation, announced on November 20 that it has administered the first dose of its CK1?-selective degrader ...

The researchers concluded that verapamil may offer metabolic benefits beyond its established cardiovascular effects. By ...

The Sharjah Academy for Astronomy, Space Sciences and Technology (SAASST) at the University of Sharjah has inaugurated the first Winter School in Astrostatistics for postgraduate students under the ...

Q3 2025 Earnings Call Transcript November 13, 2025 Innate Pharma S.A. beats earnings expectations. Reported EPS is $-0.24551, ...

Explore the critical issue of antimicrobial resistance and its devastating impact on global health and modern medicine.